Development

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Articles

Orbis Biosciences’ Optimµm Platform delivers microparticulate dosage forms with controlled-release and taste-masked properties in a single manufacturing step. 

Manufacturing Microparticles in a Single Step

The authors of the study believe it could have significant implications for the discovery of new dermatological products for major diseases such as psoriasis.

New Study Challenges Current Theories on Skin Delivery of Macromolecules

The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.

Lilly to Invest $72 Million for Insulin Manufacturing Upgrade

Through the support of the Japanese agency, Daiichi Sankyo intends to further develop its genetic vaccine platform focused around its new nucleic acid delivery technology. 

Japanese Agency Supports Daiichi Sankyo’s Genetic Vaccine Platform

Frances DeGrazio is Vice President, Marketing and Strategic Business Development at West Pharmaceutical Services, Inc.

When it comes to getting the best out of quality by design, timing is everything.

A QbD-Based Approach to Drug Packaging and Delivery

Safe and effective drug targeting with ADCs requires careful selection of drug, antibody, and linker. 

Targeting Drug Delivery with ADCs

Safe and effective drug targeting with ADCs requires careful selection of drug, antibody, and linker.

Targeting Drug Delivery with ADCs

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

New ADC therapies must overcome manufacturing challenges to reach market.

Advances in ADCs

Catalent has signed an agreement with Therachon to support preclinical and clinical development of TA-46, a novel protein being developed to treat achondroplasia.

Catalent Biologics Collaborates with Therachon to Develop Novel Protein Therapy for Achondroplasia

Joerg Zimmermann is director of Process Development and Implementation at Vetter, www.vetter-pharma.com

Prefilled dual-chamber cartridges offer several advantages. Several steps should be taken to determine if a dual-chamber system is viable for a lyophilized injectable drug product.

Formulation and Drug Delivery, Biologic Drugs